Symposien
Wenn Sie kostenlos an einer Veranstaltung teilnehmen wollen, melden Sie sich bitte hier an.
kommende Termine:
| Datum | Sprecher*in |
| 16.01.2026 | Prof. Dr. Kay Grünewald |
| 06.03.2026 | Dr. Tanja Laske |
| 20.03.2026 | Dr. Martina Anzaghe |
| 03.07.2026 | Prof. Dr. Jan Rehwinkel |
Hier finden Sie Informationen zu unseren vergangenen VIRAL Symposien
From in-silico to in-cellulo: Illuminating viral morphogenesis
27. Symposium (14.11.2025): Prof. Dr. Jens Bosse, Quantitative Virology, Institute of Virology, Hannover Medical School
Highly pathogenic Coronaviruses: from origin to intervention
26. Symposium (11.07.2025): Prof. Dr. Marcel Müller, Institute of Virology, Charité University Hospital Berlin
HPAIV H5N1 – from panzootic to pandemic?
25. Symposium (13.06.2025): Prof. Dr. Martin Beer, Friedrich-Loeffler-Institute
A disease ecology perspective on arthropod-borne viruses – insights from studies from Africa and Germany
24. Symposium (23.05.2025): Prof. Dr. Sandra Junglen, Institute of Virology, Charité – Universitätsmedizin, Berlin
How the anti-HCV immune response can drive lymphoma development
23. Symposium (09.05.2025): Dr. Christoph Schultheiss, Lab of Translational Immuno-oncology, Department of Biomedicine, University Hospital and University of Basel
Advancing Wastewater-Based Epidemiology and Preparedness: Developing a Toolbox for Detecting Circulating and Emerging Humanpathogenic Viruses
22. Symposium (21.02.2025): Dr. Marek Widera, Institut für medizinische Virologie, Universitätsmedizin Frankfurt
Mutational drivers in SARS-CoV-2 and other vertebrate RNA viruses – re-thinking virus evolution?
21. Symposium (07.02.2025): Prof. Dr. Peter Simmonds, Nuffield Department of Medicine, University of Oxford
In situ cryo-ET reveals influenza A virus assembly and vRNP interactions with hemagglutinin-remodelled membranes
20. Symposium (08.11.2024): Dr. Petr Chlanda, Department of Virology, Centre for Infectiology, Universitätsklinikum Heidelberg
Replication organelles of coronaviruses and other nidoviruses
19. Symposium (27.09.2024): Prof. Dr. Eric Snijder, Leiden University Center of Infectious Diseases, Leiden University Medical Centre
Sex differences in immunity and vaccination
18. Symposium (26.04.2024): Prof. Dr. Marylyn Addo, Zentrum für Innere Medizin, Hamburg
Development of broadly protective influenza virus vaccines
17. Symposium (08.03.2024): Prof. Dr. Florian Krammer, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York
Bunyavirus genome replication and transcription – a structural perspective
16. Symposium (23.02.2024): Dr. Maria Rosenthal, Department of Virology; Bernhard Nocht Institute for Tropical Medicine, Hamburg
Cytomegalovirus US11 and MHC-A, engaged in a coevolutionary arms race in hominids
15. Symposium (02.02.2024): Dr. Anne Halenius, Institute of Virology; University hospital Freiburg
Preparing the battle field – how cells remain vigilant against viral intruders
14. Symposium (17.11.2023): Dr. Marco Binder, Research Group: Dynamics of early viral infection and the innate antiviral response; German Cancer Research Center; Heidelberg
The journey from pandemic to endemic so far – Functional impact of adaptations in non-Spike genes of SARS-CoV-2
13. Symposium (20.10.2023): Prof. Dr. Konstantin Sparrer, Institute of molecular virology, university hospital Ulm
A new class of potent neutralizing human monoclonal antibodies targeting the Hepatitis E virus ORF2 protein
and
Pro- and antiviral host factors of hepatitis E virus entry
12. Symposium (09.06.2023):
Prof. Dr. Thomas Krey, Institute of Biochemistry, University of Lübeck: A new class of potent neutralizing human monoclonal antibodies targeting the Hepatitis E virus ORF2 protein
Dr. Volker Kinast, Medizinische Mikrobiologie und Virologie, Carl von Ossietzky Universität Oldenburg: Pro- and antiviral host factors of hepatitis E virus entry
Sex differences in SARS-CoV-2 pathogenesis
and
The ubiquitination landscape of the influenza A virus polymerase
11. Symposium (05.05.2023):
Prof. Dr. Gülsah Gabriel, Leibniz-Institut für Virologie (LIV), Hamburg: Sex differences in SARS-CoV-2 pathogenesis
Dr. Linda Brunotte, Westfälische Wilhelms-Universität, Münster: The ubiquitination landscape of the influenza A virus polymerase
Monkeypox: Past, present and future
10. Symposium (16.12.2022): Prof. Dr. Denisa Bojkova, Institut für Medizinische Virologie, Universitätsklinikum Frankfurt
Human herpesvirus diversity is altered in HLA class I binding peptides
and
Herbal medicines and UV-radiation to combat SARS-CoV-2
9. Symposium (30.09.2022):
Prof. Dr. William Palmer, Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, USA: Human herpesvirus diversity is altered in HLA class I binding peptides
Dr. Adalbert Krawczyk, Clinic for Infectiology, Medical Research Center, University Hospital Essen, Herbal medicines and UV-radiation to combat SARS-CoV-2.
Chasing the next SARS-CoV-2 variant and preparing for disease X
8. Symposium (16.09.2022): Prof. Dr. Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Hôpitaux Universitaires de Genève, Université Geneva
Investigation of the role of T cells in SARS-CoV-2 infection of non-human primates.
and
NK cell immune modulation by SARS-CoV-2
7. Symposium (11.03.2022):
Dr. Kim Hasenkrug, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton (USA): Investigation of the role of T cells in SARS-CoV-2 infection of non-human primates.
Wiebke Moskorz, Institut für Virologie, Düsseldorf: NK cell immune modulation by SARS-CoV-2.
Mutations in the spike protein of emerging SARS-CoV-2 variants affect cell tropism and neutralization sensitivity
and
Interfering with coronavirus infection – the role of type I IFN signaling for coronavirus immune control
6. Symposium (11.02.2022):
Dr. Markus Hoffmann, Deutsches Primatenzentrum, Leibniz-Institut für Primatenforschung, Göttingen: Mutations in the spike protein of emerging SARS-CoV-2 variants affect cell tropism and neutralization sensitivity
Dr. Stephanie Pfänder, Abteilung für Molekulare und Medizinische Virologie, Bochum: Interfering with coronavirus infection – the role of type I IFN signaling for coronavirus immune control
SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements
and
T cell responses in SARS-CoV-2 infections
5. Symposium (10.12.2021):
Dr. Jez Marston, Division of Infectious Diseases, New York: SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Prof. Dr. Sebastian Voigt, Institute for Virology, Essen: T cell responses in SARS-CoV-2 infections.
The Legacy of Covid-19 in Education
and
Lolli-Method to screen for SARS-CoV-2 Infection in Children
4. Symposium (19.11.2021):
Prof. Dr. Ludger Woessmann, ifo Zentrums für Bildungsökonomik, Ludwig-Maximilians-Universität München: The Legacy of Covid-19 in Education.
Dr. Felix Dewald, Institut für Virologie, Universität zu Köln: Lolli-Method to screen for SARS-CoV-2 Infection in Children.
Social determinants of COVID-19 (prevention, infection, disease severity): theory and empirical findings
3. Symposium (01.10.2021): Prof. Dr. Nico Dragano, Institut für medizinische Soziologie, Universitätsklinikum Düsseldorf
Aerosolprozesse und ihre Rolle bei der Übertragung von SARS-CoV-2
and
Stability and Inactivation of Corona viruses
2. Symposium (27.08.2021):
Prof. Dr. Andreas Held, Fachgebiet Umweltchemie und Luftreinhaltung der TU Berlin: Aerosolprozesse und ihre Rolle bei der Übertragung von SARS-CoV-2.
Dr. Stephanie Pfänder, Abteilung für Molekulare und Medzinische Virologie, Universität Bochum: Stability and Inactivation of Corona viruses.
SARS-CoV-2 evolution and immune evasion
and
T cell responses in acute and recovered COVID-19 patients
1. Symposium (25.06.2021):
Prof. Dr. Andreas Bergthaler, Research Center for Molecular Medicine of the Austrian Academy of Sciences Wien: SARS-CoV-2 evolution and immune evasion.
Prof. Dr. Ulf Dittmer, Institut für Virologie, Universität Duisburg-Essen: T cell responses in acute and recovered COVID-19 patients.
Möchten Sie Kontakt aufnehmen zu unseren Netzwerkpartnern? Kontaktieren Sie uns gerne!